DNASE1L3 and hepatocellular carcinoma: The authors found a downregulation of DNASE1L3 in hepatocellular carcinoma cells and hypothesized that decreased DNASE1L3 activity was responsible for decrease of “CCCA”-bearing cfDNA fragments in plasma of patients with hepatocellular carcinoma.